Current study evaluated the genetic variants of PIK3CA, AKT1, and AKT2, all of which are genes in PI3K/AKT pathway, to discover their potential associations with the occurrence of RP in lung cancer patients with radiotherapy. The gene discussed is AKT1; the disease is lung cancer.